Media

Press Releases

March 9, 2023
AbCheck Announces Successful Completion of Research and Development Under Grant
Download PDF
February 21, 2023
AbCheck Announces Collaboration to Apply Microfluidics Technology to the Discovery of Antibodies Against Challenging Therapeutic
Download PDF
October 6, 2020
AbCheck s.r.o. Receives Grant to Further Develop a Discovery Technology for Functional Antibodies using Microfluidics
Download PDF
June 3, 2019
Five-year Licensing Agreement Granting AbCheck Access to Icosagen’s Patented Mammalian Expression Technology
Download PDF
October 30, 2018
AbCheck s.r.o. Announces Its United States Presence with AbCheck, Inc.
Download PDF
June 28, 2018
MolMed and AbCheck sign a three-year Master Agreement for the development of new CARs targeting novel tumor antigens
Download PDF
October 25, 2017
AbCheck and Molecular Templates Announce Collaboration to Discover Therapeutic Oncology Leads
Download PDF
January 31, 2017
First Clinical Milestone Achieved in Collaboration between AbCheck and Lilly
Download PDF
October 27, 2015
AbCheck Achieves First Milestone in Pierre Fabre Partnership
Download PDF
June 17, 2015
AbCheck and Pierre Fabre Pharmaceuticals Enter Into Strategic Research Partnership
Download PDF
October 28, 2014
AbCheck Releases the AbAccel Antibody Technology for Out-Licensing
Download PDF
March 2, 2014
AbCheck Antibody Discovery Deal with Pierre Fabre
Download PDF
February 18, 2013
AbCheck Antibody Discovery Agreement with U3 Pharma
Download PDF
November 13, 2012
AbCheck adds Antibody Affinity Maturation and Developability Optimization to its Unique Phage and Yeast Display Technologies
Download PDF
October 5, 2010
Antibody Discovery Deal - First Validation of Technology and Business Approach
Download PDF

Our Services

Antibody
Discovery

Services

Antibody
Optimization

Services

Our Unique Platforms

Proprietary
Libraries

Technologies

Rabbit Mass
Humanization

Technologies

AbSieve®
Antibody
Selection

Technologies

AbAccel®
Antibody
Optimization

Technologies